SG/CALL/ELI LILLY & CO/1050/0.1/16.01.26 | Real-time Boerse Frankfurt Warrants 03:50:12 2024-05-22 am EDT | ||
| 7.19 EUR | +0.70% |
|
| Current month | +7.05% | ||
| 1 month | +37.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 7.19 | +0.70% |
| 24-05-21 | 7.14 | +13.15% |
| 24-05-20 | 6.31 | +6.05% |
| 24-05-17 | 5.95 | +0.17% |
| 24-05-16 | 5.94 | -6.01% |
Real-time Boerse Frankfurt Warrants
Last update May 22, 2024 at 03:50 am EDT
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SW8U9W |
| ISIN | DE000SW8U9W3 |
| Date issued | 2024-04-10 |
| Strike | 1,050 $ |
| Maturity | 2026-01-16 (605 Days) |
| Parity | 10 : 1 |
| Emission price | 6.99 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.26 € |
|---|---|
| Lowest since issue | 4.79 € |
| Delta | 0.4x |
| Omega | 4.132 |
| Premium | 40.41x |
| Gearing | 10.33x |
| Moneyness | 0.7649 |
| Difference Strike | 246.8 $ |
| Difference Strike % | +23.51% |
| Spread | 0.07 € |
| Spread % | 0.97% |
| Theoretical value | 7.265 |
| Implied Volatility | 33.18 % |
| Total Loss Probability | 74.70 % |
| Intrinsic value | 0.000000 |
| Present value | 7.265 |
| Break even | 1,128.81 € |
| Theta | -0.09x |
| Vega | 0.37x |
| Rho | 0.37x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
803.2
USD
Average target price
850.4
USD
Spread / Average Target
+5.88%
- Stock Market
- Warrants
- Warrant